• Hepatitis B Virus (HBV) Antibody Panel for Acute and Chronic Infection
  • Cytomegalovirus (CMV) Antibody, IgG, IgM
  • Interleukin 2 (IL2) Soluble Receptor Alpha
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • Homovanillic Acid (HVA), 24 Hour, Urine
  • Hepatitis B Surface Antibody, Qualitative
  • SARS-CoV-2 (COVID-19) Coronavirus, Molecular
  • Amylase, Body Fluid
  • HER2/neu (ERBB2) Gene Amplification, FISH, Urothelial Carcinoma
  • Estrogen/Progesterone Receptor, IHC, Semi-Quantitative
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Clostridium difficile (C. Diff) by Molecular Method
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Clostridium difficile (C. Diff) by Molecular Method
Medical Test

Clinical Utility
Access to Clostridium difficile (C. Diff) by Molecular Method is restricted.